drugset / Trial / NCT06049329

A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity

NCT06049329

Phase 1 Completed 36 enrolled Novo Nordisk A/S
RandomizedSequentialQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate if a new study drug, NNC0487-0111, is safe and how it works in the participant's body, when given as an oral tablet to Japanese participants.

Timeline

Start
2023-09-14
Primary completion
2023-12-15
Completion
2023-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject NNC0487-0111 Unknown Oral

Indications